Secukinumab retention and safety in patients with active psoriatic arthritis or ankylosing spondylitis: 2 year interim results of the observational SERENA study
Gullick, Nicola
Gullick, Nicola
Abstract
Not available
MIDER Authors
Citations
Altmetric:
Date
2022
Type
Article
Subject
Collections
Citation
10. Gaffney K, Kiltz U, Sfikakis P, Gullick N, et al. Secukinumab retention and safety in patients with active psoriatic arthritis or ankylosing spondylitis: 2 year interim results of the observational SERENA study. Rheumatology 61(s1) April 2022
Journal / Source Title
DOI
PMID
Publisher
Rheumatology